Breast cancer

Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.

We’ve helped Google Health with AI research which has the potential to improve breast cancer screening and save the NHS time and money.

The Personalised Breast Cancer Programme in Cambridge is pioneering ways to tackle hard-to-treat breast cancer.

Our scientists are rewriting the breast cancer rulebook. By looking at faults in tumour DNA, they’ve found that breast cancer is not 1 but 10 different diseases each with a different risk of coming back or spreading.

Our Grand Challenge scientists at the National Physical Laboratory are using their expertise in measurement to draw a new map of cancer. The team hopes it will point to ways to diagnose and treat the disease.

Rachel, from East Sussex, shares how her sister Thekla’s breast cancer diagnosis has affected the family so far.

New computer simulation study suggests only screening women deemed at a ‘high risk’ of breast cancer could help to reduce unnecessary diagnoses.

In the immediate aftermath, estimating the numbers affected by a breast screening error might do more harm than good.

With new cancer detection technology on the horizon, ranging from blood tests to wristbands, understanding overdiagnosis is a huge challenge.

Our researchers have discovered a way to halt breast cancer spread in mice, by blocking a molecule called asparagine. But what does this mean for patients?